SGRY, US85701Q1031

Surgery Partners stock gains as investors digest recent rally

Published on 09/02/2026 at 14:47 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Surgery Partners stock is trading higher around mid-September 2026 levels after a sharp move, with investors weighing recent price gains against fundamentals such as Q2 2026 revenue growth and current analyst targets.
SGRY, US85701Q1031, Illustration mit AI erstellt.

Surgery Partners stock (ISIN US85701Q1031) recently traded around 14.02 USD as of September 2, 2026, after closing at 13.89 USD in the prior session and opening unchanged at 13.89 USD, according to market data from Yahoo Finance.

Recent price move and valuation context

According to a MarketBeat price alert dated September 1, 2026, Surgery Partners stock rose 4.9% on that date, with the share price reaching an intraday high of 14.42 USD and last trading at 14.5650 USD, compared with a previous close of 13.89 USD.

The same MarketBeat overview notes that Surgery Partners stock is listed on the NASDAQ and is part of the S&P 400 Mid Cap universe, giving it visibility among mid-cap healthcare services peers for international investors, including those comparing it with DACH-listed healthcare names.

Analyst view and fundamentals backdrop

MarketBeat also reports that, based on compiled analyst assessments as of early September 2026, Surgery Partners carries a consensus rating described as Moderate Buy and a consensus target price of 19.45 USD, implying upside potential versus recent trading levels around 14 USD as of September 2, 2026.

While the latest quarterly figures are not detailed in the same-day sources, the current analyst target of 19.45 USD compared with a recent price near 14.02 USD suggests a gap of roughly 5.43 USD per share, which is a substantial percentage premium that investors will weigh against the companys most recent revenue and earnings performance once the next report is released.

Go deeper

More on Surgery Partners stock and filings

Additional company news, filings and ad hoc reports on Surgery Partners can be found in the dedicated ISIN overview, which aggregates recent regulatory disclosures and market commentary.

Day surgery and outpatient focus

Surgery Partners focuses on operating and managing a network of ambulatory surgery centers and surgical hospitals, emphasizing same day and short stay procedures across specialties such as orthopedics, gastroenterology and pain management, which positions the company to benefit from the long term shift of procedures out of traditional inpatient hospital settings.

Stock level in early September 2026

As of September 2, 2026, market data from Yahoo Finance shows Surgery Partners stock trading at about 14.02 USD in early trading, compared with a prior close of 13.89 USD, indicating modest gains after the 4.9% move highlighted in the MarketBeat report.

Surgery Partners stock at a glance

  • Company: Surgery Partners, Inc.
  • ISIN: US85701Q1031
  • Ticker: SGRY
  • Trading venue: NASDAQ
  • Price (as of September 2, 2026, 09:35): 14.02 USD
  • Sector / Industry: Healthcare / Healthcare Services
  • Index membership: S&P 400 Mid Cap

More on Surgery Partners

Disclaimer...
en | US85701Q1031 | SGRY | boerse | 70043526 |